NRG-HN001

Randomized Phase II AND Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
Contact phone
517..36.4.9400
Principal investigator
Gordan Srkalovic
Trial Category
Cancer
Trial SubCategory
Nasopharynx Carcinoma
Webform